Title
Implementation of MALDI-TOF MS technology for the identification of clinical isolates of Mycobacterium spp. in mycobacterial diagnosis
Date Issued
27 August 2015
Access level
metadata only access
Resource Type
journal article
Author(s)
Tudó G.
Monté M.R.
Vergara A.
López A.
Ferrer-Navarro M.
Vila J.
Gonzalez-Martin J.
Universidad de Barcelona
Publisher(s)
Springer Verlag
Abstract
A total of 243 clinical isolates of the Mycobacterium genus were studied, 143 and 100 using two protocols (Protocol v2 and Protocol v3, respectively) provided by the manufacturer. The overall correlation of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) with the standard identification methods was 63.8 %. The rate of misidentification was 3.2 %, mainly affecting very close species. In Protocol v2, the correlation was 57.3 %, being greater in solid than in liquid media (71.7 % vs. 44.7 %, p < 0.05). Albeit not significant, a trend to a greater correlation for M. tuberculosis complex compared to non-tuberculous mycobacteria (NTM) (63.6 % vs. 55.5 %) was observed. In Protocol v3, the correlation was 73 %, with no significant differences between solid and liquid media (70.8 % vs. 75 %). In conclusion, MALDI-TOF MS may play a role in identifying mycobacterial species isolated from clinical samples, being faster than sequencing and hybridization-based techniques.
Start page
1527
End page
1532
Volume
34
Issue
8
Language
English
OCDE Knowledge area
BiologÃa celular, MicrobiologÃa
Enfermedades infecciosas
Scopus EID
2-s2.0-84937976316
PubMed ID
Source
European Journal of Clinical Microbiology and Infectious Diseases
ISSN of the container
09349723
Sponsor(s)
This study was funded by Fondo de Investigación Sanitaria (grant FIS13/01752), Sociedad Española de NeumologÃa y CirugÃa Torácica (SEPAR 1007/2010), and the Spanish Network for the Research in Infectious Diseases (REIPI, RD12/0015 to GT) from the Ministry of Health, Spain.
Sources of information:
Directorio de Producción CientÃfica
Scopus